Table 1.
Trial structure of the study
| Time | Screening (−14~−1d) |
Exercise rehabilitation in clinic | Exercise rehabilitation at home | |||
| T0 Visit 1 Baseline |
T1 Visit 2 Second weekend |
T2 Visit 3 Fourth weekend |
T3 Visit 4 Eighth weekend |
T4 Visit 5 12th weekend |
||
| Assessment | ||||||
| Medical history | √ | |||||
| Inclusion/exclusion form | √ | |||||
| Consent form | √ | |||||
| Comorbidity | √ | √ | √ | √ | √ | √ |
| Concomitant medication | √ | √ | √ | √ | √ | √ |
| Physical examination | √ | √ | √ | √ | √ | √ |
| Troponin T/I | √ | √ | ||||
| BNP/NT-proBNP | √ | √ | ||||
| ECG | √ | √ | √ | √ | √ | |
| Holter | √ | √ | ||||
| NYHA classification | √ | √ | √ | √ | √ | |
| Echocardiography | √ | √ | √ | |||
| CPET | √ | √ | ||||
| 6MWT | √ | √ | ||||
| Heart failure Symptom Scale | √ | √ | ||||
| MLHFQ | √ | √ | ||||
| SF-36 | √ | √ | ||||
| BDI-II | √ | √ | ||||
| GSE | √ | √ | ||||
| Compliance | √ | √ | √ | |||
| Adverse event | √ | √ | √ | √ | ||
| Monitor and APP training | √ | |||||
The time window for each visit is ±3 d.
6MWT, 6 min walk test; BDI-II, Beck Depression Inventory; BNP/NT, B-type natriuretic peptide/N-terminal; GSE, General Self-Efficacy Scale; MLHFQ, Minnesota Living with Heart Failure Questionnaire; NYHA, New York Heart Association; SF-36, 36-Item Short Form Health Survey.